JF
FHTX icon

Jump Financial’s Foghorn Therapeutics FHTX Stock Holding History

Jump Financial’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.7K Sell
13,740
-10,389
-43% -$57K ﹤0.01% 1776
2025
Q4 		$130K Buy
+24,129
New +$109K ﹤0.01% 1809

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jump Financial's FHTX Position: Q1 2026 in Review

Jump Financial reduced its Foghorn Therapeutics (FHTX) stake by 43% in Q1 2026, selling an estimated $57K and leaving 13,740 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1776.

Jump Financial first reported a position in FHTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $130K in Q4 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Jump Financial held 13,740 shares of Foghorn Therapeutics worth $65.7K as of Q1 2026.
  • Jump Financial sold 10,389 Foghorn Therapeutics shares in Q1 2026, an estimated $57K.
  • Foghorn Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1776 holding.
  • Jump Financial first reported a position in Foghorn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Jump Financial's Foghorn Therapeutics position peaked at $130K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.